The Neuregulin-1 Receptor ErbB4 Controls Glutamatergic Synapse Maturation and Plasticity  by Li, Bo et al.
Neuron
ArticleThe Neuregulin-1 Receptor ErbB4 Controls
Glutamatergic Synapse Maturation and Plasticity
Bo Li,1 Ran-Sook Woo,2 Lin Mei,2 and Roberto Malinow1,*
1Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA
2Program of Developmental Neurobiology and Department of Neurology, Institute of Molecular Medicine and Genetics,
Medical College of Georgia, Augusta, GA 30912, USA
*Correspondence: malinow@cshl.edu
DOI 10.1016/j.neuron.2007.03.028SUMMARY
Neuregulin-1 (NRG1) signaling participates in
numerous neurodevelopmental processes.
Through linkage analysis, nrg1 has been
associated with schizophrenia, although its
pathophysiological role is not understood. The
prevailing models of schizophrenia invoke hy-
pofunction of the glutamatergic synapse and
defects in early development of hippocampal-
cortical circuitry. Here, we show that the erbB4
receptor, as a postsynaptic target of NRG1,
plays a key role in activity-dependent matura-
tion and plasticity of excitatory synaptic struc-
ture and function. Synaptic activity leads to the
activation and recruitment of erbB4 into the
synapse. Overexpressed erbB4 selectively en-
hances AMPA synaptic currents and increases
dendritic spine size. Preventing NRG1/erbB4
signaling destabilizes synaptic AMPA receptors
and leads to loss of synaptic NMDA currents
and spines. Our results indicate that normal ac-
tivity-driven glutamatergic synapse develop-
ment is impaired by genetic deficits in NRG1/
erbB4 signaling leading to glutamatergic hypo-
function. These findings link proposed effectors
in schizophrenia: NRG1/erbB4 signaling pertur-
bation, neurodevelopmental deficit, and gluta-
matergic hypofunction.
INTRODUCTION
The function of NRG1 in the brain has gained much atten-
tion since the initial discovery (Stefansson et al., 2002) and
subsequent confirmation (Harrison and Law, 2006; Harri-
son andWeinberger, 2005; Scolnick et al., 2006) that nrg1
gene is linked to schizophrenia. Further studies showed
that erbB4, a receptor of NRG1, is also associated with
schizophrenia (Law et al., 2007; Norton et al., 2006a; Sil-
berberg et al., 2006). A change in the expression level of
NRG1 isoforms (Hashimoto et al., 2004; Law et al., 2006;
Petryshen et al., 2005) or erbBs (Hakak et al., 2001; Silber-
berg et al., 2006; Sugai et al., 2004) has been reported inschizophrenia patients. These studies strongly support
the hypothesis that a perturbation in NRG1 signaling in
the brain can contribute to the etiology of schizophrenia.
NRG1 has multiple biological functions (Falls, 2003). In
the peripheral nervous system (PNS), it regulates target
cell differentiation (Hippenmeyer et al., 2002), neurotrans-
mitter receptor expression (Buonanno and Fischbach,
2001; Chu et al., 1995; Falls et al., 1993; Fischbach and
Rosen, 1997; Jo et al., 1995; Schaeffer et al., 2001; Usdin
and Fischbach, 1986; Wolpowitz et al., 2000), NMJ or in-
terneuronal PNS synapse development (Lin et al., 2000;
Morris et al., 1999; Woldeyesus et al., 1999; Wolpowitz
et al., 2000; Yang et al., 1998), and Schwann cell survival
(Escher et al., 2005; Kummer et al., 2006).
In the brain, NRG1 signaling regulates radial glia forma-
tion and neuronal migration (Anton et al., 1997; Rio et al.,
1997), oligodendrocyte development and axon myelina-
tion (Calaora et al., 2001; Canoll et al., 1996; Fernandez
et al., 2000; Schmucker et al., 2003; Vartanian et al.,
1994, 1999), axon path finding (Lopez-Bendito et al.,
2006), dendritic development (Gerecke et al., 2004; Rieff
and Corfas, 2006), and the expression of neurotransmitter
receptors (Liu et al., 2001; Okada and Corfas, 2004; Ozaki
et al., 1997; Rieff et al., 1999; Stefansson et al., 2002; Xie
et al., 2004).
NRG1 function is largelymediated by a class of receptor
tyrosine kinases including erbB2, erbB3, and erbB4 (Falls,
2003; Yarden and Sliwkowski, 2001). ErbB4 is likely to
be the major mediator of NRG1 functions in the brain, es-
pecially for those related to schizophrenia, since first,
erbB4, but not erbB2 or erbB3, mutant animals share
many neural and behavioral defects with NRG1 mutants
(Falls, 2003; Stefansson et al., 2002); second, erbB4 gene,
but not erbB2 or 3, has been shown to associate with
schizophrenia (Law et al., 2007; Norton et al., 2006a;
Silberberg et al., 2006); third, altered NRG1/erbB4 signal-
ing has been reported in the brain of schizophrenia
patients (Hahn et al., 2006).
In many brain areas, NRG1 is expressed at synaptic re-
gions (Chaudhury et al., 2003; Law et al., 2004; Ozaki
et al., 2000), and its processing can be regulated by neu-
ronal activity (Bao et al., 2003; Eilam et al., 1998; Ozaki
et al., 2004). Recent biochemical studies showed that
erbB4 is highly enriched in the postsynaptic density
(PSD) of excitatory synapses and interacts with PSD-95
(Garcia et al., 2000; Huang et al., 2000), a majorNeuron 54, 583–597, May 24, 2007 ª2007 Elsevier Inc. 583
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trol synaptic function (Ehrlich and Malinow, 2004; El-Hus-
seini et al., 2000), suggesting an important role of erbB4 in
these synapses. Moreover, in the hippocampus, NRG1
mRNA is highly expressed in the CA3 area, a region pre-
synaptic to the CA1 area which displays erbB4 expression
(Law et al., 2004; Okada and Corfas, 2004). These findings
suggest that NRG1/erbB4 signalingmight be important for
the function or development of glutamatergic synapse and
circuitry in the brain.
Here, by manipulating NRG1/erbB4 signaling at the
hippocampal CA3-CA1 pathway, we demonstrate that
postsynaptic erbB4 controls activity-dependent matura-
tion and plasticity of excitatory synaptic structure and
function. In particular, NRG/erbB4 signaling is positively
regulated by synaptic activity. In turn, NRG/erbB4 signal-
ing is also required for activity-dependent AMPA receptor
synaptic incorporation and stabilization as well as mainte-
nance of spine structure. As a result, interruption of signal-
ing frompresynaptic NRG1 to postsynaptic erbB4 leads to
impaired synaptic development and depressed glutama-
tergic function. Our study indicates that NRG1/erbB4 sig-
naling plays an important role in glutamatergic synapses
and suggests a mechanism by which genetic or activity-
dependent perturbation of this pathway can contribute to
the etiology of schizophrenia.
RESULTS
Neuronal Activity Regulates ErbB4 Activation
and Localization
Previous biochemical studies have shown that erbB4 is
enriched in the PSD fraction of excitatory synapse in the
brain (Garcia et al., 2000; Huang et al., 2000). However,
it is not clear how erbB4 synaptic localization is achieved
and how its localization and function are regulated. Since
NRG1 processing or release is regulated by neuronal ac-
tivity (Bao et al., 2003; Eilam et al., 1998; Han and Fisch-
bach, 1999; Ozaki et al., 2004), we hypothesized that neu-
ronal activity also regulates erbB4 activation and its
recruitment and stabilization in the synapse. We predicted
that synaptic erbB4 should have a higher phosphorylation
level than extrasynaptic erbB4, and changing neuronal ac-
tivity should change erbB4 phosphorylation and distribu-
tion. As expected, erbB4 isolated from the PSD fraction
displayed a greater degree of phosphorylation than erbB4
in the brain homogenate (homogenate, 1 ± 0.05; PSD,
4.1 ± 0.55; n = 4 experiments; p < 0.01; Figure 1A), indicat-
ing synaptic erbB4 is preferentially activated. Moreover,
increasing neuronal activity by treating hippocampal sli-
ces with picrotoxin for 1 hr markedly increased erbB4
phosphorylation in the PSD (control, 1 ± 0.1; picrotoxin,
5 ± 0.3; n = 4 experiments; p < 0.01; Figure 1B), whereas
inhibiting neuronal activity by elevated concentration of
MgCl2 (Zhu et al., 2000) or TTX for 1 hr significantly de-
creased erbB4 phosphorylation in the PSD (control, 1 ±
0.12; MgCl2, 0.23 ± 0.08; TTX, 0.16 ± 0.06; n = 3 experi-
ments; p < 0.01 for both MgCl2 and TTX compared with584 Neuron 54, 583–597, May 24, 2007 ª2007 Elsevier Inc.control; Figures 1C and 1D). Interestingly, inhibition of
neuronal activity also reduced the total amount of erbB4
in the PSD fraction (Figures 1C and 1E).
To directly visualize the subcellular distribution of
erbB4, we tagged recombinant erbB4 in the extracellular
region with a pH-sensitive form of GFP, super-ecliptic
pHluorin (SEP), which we have previously shown to be
a marker for receptors on the cell surface (Kopec et al.,
2006). After transfection of CA1 pyramidal cells in organo-
typic hippocampal slices with SEP-erbB4 together with
a red fluorescent protein, tomato DsRed, as a cellular
marker, the subcellular distribution of erbB4 was exam-
ined by dual-channel two-photon laser-scanning micros-
copy (TPLSM) (Kopec et al., 2006). We found that SEP-
erbB4 is highly enriched on the surface of spines of CA1
pyramidal cells (Figures 1F, 1G, and 1H).
Consistent with the biochemical results, our imaging
data also showed that erbB4 subcellular localization is
regulated by neuronal activity. When transfected slices
are maintained in normal media, SEP-erbB4 is highly
enriched on the surface of spines. However, maintaining
slices with elevated concentration of Mg2+ markedly re-
duced this enrichment (normal media, 47 ± 6.3, n = 212
spines from three cells; Mg2+-treated, 5.9 ± 0.1, n = 266
spines from four cells; p < 0.01; Figures 1G, 1H, and 1I).
To test if erbB4 activation is required for its spine enrich-
ment, we expressed an erbB4mutant that lacks the kinase
activity due to a point mutation in the kinase domain,
which has been shown to function as a dominant-negative
erbB4 (Yang et al., 2005). The kinase-dead erbB4 (SEP-
erbB4-KD) is much less enriched on the surface of spine
(11.1 ± 0.3, n = 417 spines from four cells; p < 0.01 com-
pared with SEP-erbB4). Treatment with Mg2+ further re-
duced the enrichment of SEP-erbB4-KD on the spine sur-
face (6.4 ± 0.2, n = 163 spines from four cells; p < 0.01
compared with nontreated SEP-erbB4-KD; Figures 1G,
1H, and 1I).
These data indicate that neuronal activity regulates
erbB4 activation and erbB4 activation is required for its
synaptic recruitment or stabilization and suggest that
erbB4 plays an important role in glutamatergic synapses.
Activity-Dependent ErbB4 Regulation
of Synaptic Transmission
To test if erbB4 is important for synaptic function at hippo-
campal CA3-CA1 synapse, we first examined the effects
of erbB4 overexpression on synaptic transmission by
simultaneous recordings of evoked EPSCs from aCA1 py-
ramidal neuron overexpressing erbB4 and an adjacent
control neuron.Overexpression of either nontagged erbB4
(together with GFP as a cellular marker) or SEP-erbB4
results in a potentiation of AMPA receptor (AMPAR)-medi-
ated transmission (control, 1 ± 0.1; erbB4, 1.8 ± 0.2; n = 31
pairs; p < 0.01), but not NMDA receptor (NMDAR)- (con-
trol, 1 ± 0.2; erbB4, 0.83 ± 0.1; n = 27 pairs; p > 0.05) me-
diated transmission (Figure 2A). Overexpression of erbB4
isoform CYT-1, or isoform CYT-2, which lacks a PI3-ki-
nase binding domain, had similar effects (data not shown),
Neuron
ErbB4 Controls Synapse Maturation and PlasticityFigure 1. Activity-Dependent Regulation of ErbB4 Phosphorylation and Localization in the Synapse
(A) Enrichment of phosphorylated erbB4 in PSD. ErbB4 was precipitated with anti-erbB4 antibodies from either brain homogenates (H) or PSD frac-
tion. Samples were adjusted to reveal equal amounts of precipitated erbB4 (middle panel; lanes 1 versus 3, and 2 versus 4). Precipitated erbB4 was
resolved on SDS-PAGE and immunoblotted with anti-phosphotyrosine antibodies (upper panel). Equal amounts of protein were also loaded from
either homogenates or PSD fraction (lower panel; lanes 1 versus 3, and 2 versus 4) for detection of PSD-95 as a control for successful isolate of
PSD fraction. Phosphorylated erbB4 in PSD was quantified and normalized as fold difference compared to that in H (bar graph on the right side).
(B–D) Phosphorylation of erbB4 in PSD is activity dependent. ErbB4 was precipitated from PSD isolated from brain slices and examined by western
blot as in (A).
(B) Picrotoxin (100 mM)-treated sample showed elevated erbB4 phosphorylation. Quantification is on the right side.
(C and D) Treatment with either TTX or elevated Mg2+ resulted in a reduction of erbB4 phosphorylation in PSD and also a reduction of total amount of
erbB4 (E) in PSD.
(F) Representative images of the dendritic branches of a hippocampal CA1 pyramidal neuron transfected with SEP-erbB4 (green) together with
tomato DsRed (red) acquired with TPLSM. ErbB4 is highly enriched in spines. Scale bar, 10 mm.
(G) Quantification of enrichment of SEP-erbB4 and SEP-erbB4-KD in spines after different treatment (**p < 0.01 by K-S test).
(H) Same data as in (G) displayed as cumulative distribution.
(I) Ratio images (green/red) of cells expressing tomato DsRed and indicated SEP-tagged receptor are shown for different conditions. Blue depicts low
receptor density, and red depicts high density. Scale bar, 5 mm.
Data are reported as mean ± standard error of the mean (SEM).suggesting that the PI3-kinase binding domain is not
required for potentiating AMPAR-mediated synaptic
transmission.To examine the function of endogenous erbB4, we
employed RNA interference (RNAi) to knock down erbB4
protein level. Neurons were infected with a Lenti virusNeuron 54, 583–597, May 24, 2007 ª2007 Elsevier Inc. 585
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ErbB4 Controls Synapse Maturation and PlasticityFigure 2. ErbB4 Controls Synaptic Transmission in an Activity-Dependent Manner
(A) Upper: Representative traces of EPSCs recorded simultaneously from a pair of neurons (black, control neuron; green, neuron overexpressing
erbB4; EPSCs from both60 and +40 mV holding potentials are shown). Scale bars, 50 ms and 20 pA. Lower: quantification of the EPSCs mediated
by both AMPAR and NMDAR from pairs of control and erbB4-overexpressing neurons. The EPSC amplitude was normalized to the mean value of
EPSCs from control neurons. The same way of data display applies for all the subsequent electrophysiology data.
(B) Same as (A), except that the recordings were made from pairs of control and erbB4 RNAi-expressing neurons.
(C) Same as (B), except that the recordings were made from pairs of control and erbB4-KD-expressing neurons.
(D) Left: representative traces for recordings from paired control and erbB4-overexpressing neurons under MgCl2-, APV-, or AG1478-treated
condition. Right: quantification of the EPSCs mediated by both AMPAR and NMDAR under different conditions.
(E) Left: representative traces for recordings from paired control and erbB4-KD-expressing neurons under MgCl2- or AG1478-treated condition.
Right: quantification of the EPSCs mediated by both AMPAR and NMDAR under different conditions. *p < 0.05; **p < 0.01. Scale bars, 50 ms and
20 pA.
Data are reported as mean ± SEM.expressing, via a dual-promoter system, GFP (as amarker
for infected cells) and short hairpin RNAs specifically tar-
geting different regions of erbB4 transcript. Three different
short hairpin RNAs reduced erbB4 protein expression to
different degrees, with hairpin number two (hp2) being
most effective (see Figure S1A in the Supplemental Data
available with this article online). After infecting CA1 cells,
hp2 significantly depressedboth AMPAR- (control, 1 ± 0.2;586 Neuron 54, 583–597, May 24, 2007 ª2007 Elsevier Inc.hp2, 0.65 ± 0.1; n = 10 pairs; p < 0.05) and NMDAR- (con-
trol, 1 ± 0.1; hp2, 0.67 ± 0.1; n = 8 pairs; p < 0.05) mediated
transmission (Figure 2B). Hp3 also depressed synaptic
transmission, whereas hp1, which was less effective in
knocking down erbB4 expression, failed to suppress
transmission (Figure S1B). To further test the specificity
of erbB4 RNAi, hp2 was expressed together with an erbB4
construct that has silent mutations that avoid targeting by
Neuron
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Maturation
(A) Representative traces of miniature events
recorded from control neurons (left) or neurons
expressing erbB4 RNAi (right) at different de-
velopmental stages (4 versus 7 DIV). Scale
bars, 1 s and 20 pA.
(B) Cumulative distribution of interevent inter-
vals for the miniature events recorded as in
(A). p < 0.01 between control 4 DIV and 7 DIV
and between control and RNAi at 7 DIV, by
K-S test).
(C) Quantification of the change in miniature
event frequencyduringdevelopment for control
neurons or neurons expressing erbB4 RNAi.
(D) Quantification of miniature event amplitude
for control neurons and neurons expressing
erbB4 RNAi at different development stages
(4 versus 7 DIV). *p < 0.05.
Data are reported as mean ± SEM.hp2 (erbB4-rescue). Like expressing erbB4 alone, ex-
pressing of hp2 together with erbB4-rescue resulted in
a potentiation of AMPAR-mediated transmission but no
effect on NMDAR-mediated transmission (Figure S1C),
indicating that erbB4 RNAi is specific.
To determine whether the kinase activity of erbB4 or
other functional domains are responsible for the effects
of erbB4, we tested the effects of erbB4-KD. ErbB4-KD
depressed both AMPAR- (control, 1 ± 0.1; erbB4-KD,
0.47 ± 0.1; n = 16 pairs; p < 0.01) and NMDAR- (control,
1 ± 0.2; erbB4-KD, 0.55 ± 0.1; n = 14 pairs; p < 0.05) me-
diated transmission (Figure 2C), similar to the effects of
erbB4 RNAi, suggesting erbB4-KD functions as a domi-
nant-negative. These data indicate that erbB4 controls ex-
citatory synaptic transmission at the CA3-CA1 synapse.
Since erbB4 activation and synaptic localization are ac-
tivity dependent, it is likely that the function of NRG1/
erbB4 in the glutamatergic synapse also depends on neu-
ronal activity. To test this, we incubated organotypic hip-
pocampal slices in medium containing elevated concen-
tration of Mg2+ and then tested the effects of erbB4 and
erbB4-KD on synaptic transmission in CA3-CA1 synapse.
Mg2+ treatment prevented the potentiation effect of erbB4
on AMPAR-mediated transmission (AMPAR, control 1 ±
0.2; erbB4 0.83 ± 0.1; n = 10 pairs; p > 0.05; NMDAR,
control 1 ± 0.2; erbB4 0.68 ± 0.1; n = 9 pairs; p > 0.05; Fig-
ure 2D) and occluded the depression effects of erbB4-KD
on both AMPAR- and NMDAR-mediated transmission
(AMPAR, control 1 ± 0.1; erbB4 0.83 ± 0.1; n = 9 pairs; p >
0.05; NMDAR, control 1 ± 0.1; erbB4 0.95 ± 0.1; n = 9
pairs; p > 0.05; Figure 2E). APV also blocked the potenti-
ating effect of erbB4 (AMPAR, control 1 ± 0.1; erbB4
0.63 ± 0.1; n = 8 pairs; p > 0.05; NMDAR, control 1 ±
0.2; erbB4 0.61 ± 0.2, n = 7 pairs; p > 0.05; Figure 2D), in-
dicating that NMDAR activation is involved. Treatmentwith either Mg2+ or APV had a tendency to depress trans-
mission. Since blocking activity inhibited phosphorylation
of synaptic erbB4 (Figure 1) but not extrasynaptic erbB4
(data not shown), overexpression of erbB4 in the presence
of activity blockers would shift erbB4 activation pattern
away from the synapse. This may trap glutamate recep-
tors away from the synapse (see below). An erbB4 kinase
inhibitor, AG1478 (Fukazawa et al., 2003), also prevented
the effects of erbB4 and occluded the effects of erbB4-KD
(Figures 2D and 2E). These data further indicate that nor-
mal spontaneous neuronal activity is required to activate
erbB4, and activation of erbB4 kinase is necessary for
its synaptic function.
ErbB4 Regulates Synaptic Maturation
ErbB4 might affect synaptic transmission by controlling
synaptic maturation that occurs during the period that
constructs are expressed. To test this hypothesis, we ex-
amined the effects of erbB4 RNAi on miniature EPSC
(mEPSC) of CA1 pyramidal cells. Normally, there is a sig-
nificant increase in mEPSC frequency (4 DIV, 3.3 ± 0.7
per min, n = 10 cells; 7 DIV, 17.5 ± 4.5 per min, n = 10 cells;
p < 0.05) and a small increase in mEPSC amplitude (4 DIV,
21.7 ± 0.8 pA, n = 300 events from 10 cells; 7 DIV, 25.8 ±
0.5 pA, n = 1330 events from 10 cells; p < 0.05) during early
development of CA3- CA1 synapse (Figures 3A–3D; Barria
and Malinow, 2005). The maturation process of excitatory
synapse involves spontaneous activity-dependent plas-
ticity (SAP) (Barria and Malinow, 2005; Kolleker et al.,
2003; Zhu et al., 2002), which shares many properties with
a more acute form of plasticity, long-term potentiation
(LTP), including its dependence on CaMKII and NMDAR
activation (Barria and Malinow, 2005). ErbB4 RNAi largely
arrested the increase in mEPSC frequency during devel-
opment (4 DIV, 2.8 ± 0.6 per min, n = 8 cells; 7 DIV,Neuron 54, 583–597, May 24, 2007 ª2007 Elsevier Inc. 587
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ing Spine Morphology
(A) Representative images of apical dendrites
from CA1 pyramidal neurons expressing GFP
only (control) or erbB4 RNAi and GFP, acquired
with TPLSM.
(B) Quantification of the spine size for control
neurons and neurons expressing erbB4 RNAi.
(C) Quantification of the spine density for con-
trol neurons and neurons expressing erbB4
RNAi.
(D) Representative images of apical dendrites
from CA1 pyramidal neurons expressing to-
mato DsRed only (control), tomato DsRed and
SEP-erbB4-KD (erbB4-KD), or tomato DsRed
and SEP-erbB4 (erbB4). Only red channel is
shown for comparing spine morphology.
(E) Quantification of spine size for control,
erbB4-KD-, or erbB4-expressing neurons.
(F) Quantification of spine density for control,
erbB4-KD-, or erbB4-expressing neurons.
*p < 0.05; **p < 0.01. Scale bar, 10 mm.
Data are reported as mean ± SEM.6.4 ± 2.3 per min, n = 10 cells; p > 0.05; Figures 3B and 3C)
without significantly influencing mEPSC amplitude (4 DIV,
22.4 ± 1.1 pA, n = 212 events from 8 cells; 7 DIV, 24.9 ± 0.8
pA, n = 461 events from 10 cells; p > 0.05 compared with
control for both developmental stages; Figure 3D). These
data indicate that erbB4 mediated signaling is critical for
normal synaptic maturation.
ErbB4 Is Critical in Maintaining Spine Morphology
Since erbB4 controls synaptic maturation, it is reasonable
to speculate that erbB4 signaling also controls the size or
number of dendritic spines, where excitatory synapses are
placed (Harris and Kater, 1994). Indeed, erbB4 RNAi dra-
matically reduced spine density (control, 0.45 ± 0.03 per
mm, n = 26 dendritic sections from six cells; erbB4 RNAi,
0.22 ± 0.03 per mm, n = 21 dendritic sections from 6 cells;
p < 0.01; Figures 4A and 4C) and also significantly reduced
spine size, although to a lesser extent (control, 1 ± 0.03,
n = 540 spines from six cells; erbB4 RNAi, 0.8 ± 0.04, n =
221 spines from six cells; p < 0.01; Figure 4B). On the other
hand, overexpression of erbB4 increased spine size (con-
trol, 1 ± 0.08, n = 303 spines from four cells; erbB4, 1.5 ±
0.08, n = 291 spines from four cells; p < 0.01; Figures 4D
and 4E) but did not affect spine density (control, 0.6 ±
0.05 per mm, n= 9dendritic sections from four cells; erbB4,
0.58 ± 0.08 per mm, n = 10 dendritic sections from four
cells; p > 0.05; Figure 4F). This suggests that erbB4 activ-
ity is critical for the maintenance of existing spines but is
not sufficient for the formation of new spines. Interestingly,
erbB4-KD only reduced spine size (erbB4-KD, 0.8 ± 0.04,
n = 337 spines from four cells; p < 0.05 compared with
control; Figures 4D and 4E) but did not change spine den-
sity (erbB4-KD, 0.56 ± 0.03 per mm, n = 9 dendritic sec-
tions from four cells; p > 0.05 compared with control;
Figure 4F), an effect that is different from erbB4 RNAi
(Figure 4C). Since erbB4-KD still has other functional do-
mains intact, such as the PDZ ligand domain (see below),588 Neuron 54, 583–597, May 24, 2007 ª2007 Elsevier Inc.it is likely that domains in erbB4 other than the kinase do-
main are also involved in maintaining spine structure.
The PDZ Interaction Is Important for ErbB4 Function
Previous studies have shown that the C-terminal end of
erbB4 interacts with the PDZ domains of MAGUK proteins
including PSD-95, and this interaction regulates the acti-
vation of erbB4 kinase (Huang et al., 2000; Xie et al.,
2007). To test whether the erbB4 interaction with a
MAGUK protein is important for its synaptic function, we
expressed an erbB4mutant, erbB4-DV, which has a single
amino acid deletion at the very end of C terminus that
abolishes its PDZ interaction (Huang et al., 2000).
ErbB4-DV lost the ability to enlarge spine size (control, 1 ±
0.06, n = 200 spines from three cells; erbB4-DV, 1 ± 0.05;
n = 229 spines from four cells; p > 0.05; Figures 5A–5C)
and potentiate synaptic transmission (control AMPA, 1 ±
0.1; erbB4-DV AMPA, 1 ± 0.1, n = 13 pairs, p > 0.05; con-
trol NMDA, 1 ± 0.1; erbB4-DV NMDA, 0.86 ± 0.16, n = 12
pairs, p > 0.05; Figure 5D). Moreover, erbB4-DV is less en-
riched in the spine compared with wild-type erbB4 (erbB4,
47 ± 6.3, n = 212 spines from three cells; erbB4-DV, 31 ±
4, n = 229 spines from four cells; p < 0.01; Figure 5E) likely
due to its inefficiency in activation (Huang et al., 2000),
since activation of erbB4 is required for its spine enrich-
ment (see Figure 1). However, it is also possible that
interaction with a MAGUK protein directly controls erbB4
trafficking. We conclude that, besides the kinase domain,
the PDZ ligand domain of erbB4 is also important for its
proper synaptic localization and function.
ErbB4 Mediates the Function of NRG1
Although there is evidence showing that NRG1 is ex-
pressed in axons in the PNS (Fernandez et al., 2000; Ta-
veggia et al., 2005), it is not clear if NRG1 is expressed
in the presynaptic terminals of CNS glutamatergic syn-
apse, mainly due to the lack of a high quality antibody to
Neuron
ErbB4 Controls Synapse Maturation and PlasticityFigure 5. The PDZ Interaction Is Impor-
tant to ErbB4 Function and Localization
(A) Representative images of apical dendrites
from CA1 pyramidal neurons expressing to-
mato only (control) or SEP-erbB4-DV with to-
mato, acquired with TPLSM. Scale bar, 5 mm.
(B) Quantification of the spine size for control
neurons and neurons expressing erbB4-DV.
(C) Quantification of the spine density for
control neurons and neurons expressing
erbB4-DV.
(D) Left: representative traces of EPSCs re-
corded simultaneously from a pair of neurons
(black, control neuron; green, neuron overex-
pressing erbB4-DV). Scale bars, 50 ms and
20 pA. Right, quantification of the EPSCsmedi-
ated by both AMPAR and NMDAR from pairs of
neurons.
(E) Quantification of spine enrichment of SEP-
erbB4 and SEP-erbB4-DV.
Data are reported as mean ± SEM.visualize the subcellular localization of NRG1. Moreover,
since erbB4 has ligands other than NRG1 and erbB4 can
form functional heteromers with other receptors such as
erbB1 (Carpenter, 2003), a perturbation of erbB4 function
may disrupt signaling pathways other than that mediated
by NRG1. To directly address these questions, we em-
ployed RNAi to knock down the expression of endoge-
nous NRG1 in the presynaptic, CA3 pyramidal neurons.
Three hairpin-like RNAs that target sequences that are
shared by all major NRG1 isoforms, types I, II, and III,
were expressed using Lenti viruses that coexpress GFP
or tDimer DsRed to serve as infection markers. The effect
of the hairpins on NRG1 expression was confirmed in both
hippocampal neurons and HEK293 cells transfected with
different NRG1 isoforms (Figures S2A–S2D). A hairpinthat effectively reduced the expression of both NRG1
type I and III was used for subsequent experiments.
We reasoned that if the effects of erbB4 manipulation,
as described above, are due to a disruption of presynaptic
NRG1-mediated signaling, presynaptic knock down of
NRG1would occlude these effects. That is, a postsynaptic
cell not expressing erbB4 RNAi would be depressed by
presynaptic NRG1 RNAi to the same level as a postsynap-
tic cell expressing erbB4 RNAi. To test this, we infected
CA3 area with a high-titer Lenti virus expressing NRG1
RNAi together with tDimer. CA1 area was infected with
low-titer Lenti virus expressing erbB4 RNAi together with
GFP. A stimulating electrode was positioned in the heavily
infected (red) cell body area in CA3 (Figure 6A) to activate
CA3 axons expressing NRG1 RNAi. SimultaneousFigure 6. ErbB4Mediates the Function of
Presynaptic NRG1
(A) A diagram of the recording configuration for
stimulating CA3 NRG1 RNAi-expressing neu-
rons (red), and recording a pair of CA1 neurons,
which may include a noninfected neuron and
an adjacent neuron expressing erbB4 RNAi or
erbB4-KD (green).
(B and C) Representative traces from a pair of
neurons recorded as in (A). Scale bars, 50 ms
and 20 pA.
(D) Quantification of the EPSCs mediated by
both AMPAR and NMDAR from pairs of control
and erbB4 RNAi-expressing neurons recorded
as in (A).
(E) Quantification of the EPSCs mediated by
both AMPAR and NMDAR from pairs of control
and erbB4-KD expressing neurons recorded as
in (A).
Data are reported as mean ± SEM.Neuron 54, 583–597, May 24, 2007 ª2007 Elsevier Inc. 589
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infected and erbB4 NRAi-infected (green) pyramidal cells
in the CA1 region (Figure 6A). As expected for occlusion,
the depressing effects of erbB4 RNAi on both AMPAR-
and NMDAR-mediated transmission were abolished by
NRG1 knockdown (AMPAR, control 1 ± 0.2, erbB4 RNAi
1.1 ± 0.1, n = 18 pairs, p > 0.05; NMDAR, control 1 ± 0.2,
erbB4 RNAi 0.85 ± 0.2, n = 17 pairs, p > 0.05; Figures 6B
and 6D). When presynaptic NRG1 RNAi was expressed
together with a NRG1 construct with silent mutations
that avoid RNAi targeting, the effects of postsynaptic
expression of erbB4 RNAi on synaptic transmission
were restored, suggesting that NRG1 RNAi is specific
(Figure S2E). Furthermore, similar results were also ob-
tained for erbB4-KD (AMPAR, control 1 ± 0.1, erbB4-KD
0.87 ± 0.1, n = 14 pairs, p > 0.05; NMDAR, control 1 ± 0.2,
erbB4-KD 0.99 ± 0.2, n = 12 pairs, p > 0.05; Figures 6C
and 6E). These results indicate that postsynaptic erbB4
mediates the function of presynaptic NRG1 to control
CA3-CA1 synapses.
NRG1/erbB4 Signaling Is Critical for Structural
and Functional Synaptic Plasticity
Since NRG1/erbB4 regulates spontaneous activity-de-
pendent plasticity (SAP), which shares mechanisms with
LTP, we speculated that NRG1/erbB4 might also be im-
portant for LTP. To test this, either SEP-erbB4 or SEP-
erbB4-KD was expressed in CA1 pyramidal cells, and the
slices were incubated in elevated Mg2+ during the period
of both erbB4 and erbB4-KD expression, which normal-
izes NMDA current between infected and noninfected
cells (Figures 2D and 2E). This will preclude the effect
of NMDA receptor depression on synaptic plasticity. A
chemical form of LTP (cLTP) (Kopec et al., 2006) com-
bined with TPLSMwas employed to track changes in indi-
vidual spines induced by synaptic plasticity. Similar to
what we have shown previously, cLTP, which induces
transient synchronized neuronal bursting in organotypic
slices (Kopec et al., 2006), induced a rapid and persistent
increase in spine size (spine size at 5, 40, and 70 min was
1.7 ± 0.1, 1.6 ± 0.1, and 1.7 ± 0.1, respectively, over base
line; n = 135 spines from four cells; p < 0.01 for each timepoint; Figure 7A). In addition, cLTP also induced a rapid
and persistent increase in the amount of erbB4 receptors
on the surface of spines (spine SEP-erbB4 at 5, 40, and 70
min was 1.36 ± 0.1, 1.24 ± 0.1, and 1.27 ± 0.1, respec-
tively, over base line; n = 135 spines from four cells; p <
0.01 for 5 min and p < 0.05 for 40 and 70 min time points;
Figure 7A), further supporting the finding that neuronal ac-
tivity recruits erbB4 into the synapse. The increase of
erbB4 on the spine surface is unlikely to be a passive re-
cruitment due to the increase in spine size, as other sur-
face proteins, such as NMDARs, do not increase in spines
during cLTP (Kopec et al., 2006). On the other hand, SEP-
erbB4-KD largely prevented the spine size increase in-
duced by cLTP (spine size at 5, 40, and 70 min was 1.2 ±
0.1, 1 ± 0.1, and 1.1 ± 0.1, respectively, over base line; n =
121 spines from four cells; p < 0.01 compared with SEP-
erbB4 for each time point; Figure 7B), and cLTP did not
increase the content of SEP-erbB4-KD on spine surface
(spine SEP-erbB4-KD at 5, 40, and 70 min was 1 ± 0.04,
0.87 ± 0.04, and 0.98 ± 0.1, respectively, over base line;
n = 135 spines from four cells; p > 0.05; Figure 7B). This
suggests that the normal NRG1/erbB4 signaling is re-
quired for cLTP induction and erbB4 trafficking.
Activity-dependent activation of erbB4 might result
from the activity-dependent processing or release of
NRG1 from the presynaptic termini, since it has been
shown that NRG1 type I expression, processing, or re-
lease is regulated by neuronal activity, including LTP like
stimulation (Eilam et al., 1998; Han and Fischbach, 1999;
Ozaki et al., 2004). Less is known about the activity-de-
pendent regulation of NRG1 type III, although its process-
ing has also been shown to be activity dependent (Bao
et al., 2003). To directly visualize NRG1 type III, we tagged
NRG1 type III with SEP in the extracellular region (Wang
et al., 2001). After infection of pyramidal neurons with a
double-promoter Sindbis virus expressing SEP-NRG1
type III together with tDimer as a morphological marker,
the subcellular distribution of SEP-NRG1 type III was
examined with TPLSM. SEP-NRG1 type III was readily de-
tectable on the surface of axons, especially on bouton-like
structures (Figure 7C). To test if the distribution of NRG1
is regulated by neuronal activity, time-lapse TPLSM wasFigure 7. NRG1/ErbB4 Signaling Regulates Structural and Functional Plasticity
(A) Left: images of a CA1 pyramidal cell expressing tomato DsRed and SEP-erbB4 taken at 30 and +40 min relative to cLTP induction. Scale
bar, 5 mm. Right: Quantification of the integrated red (volume) and green (erbB4) fluorescence for spines, as well as the mean red (tomato DsRed)
and mean green (erbB4) value for dendrites at each time point during the cLTP experiments. Each region of interest is normalized to its value at
the 10 min time point. The black bar denotes cLTP induction.
(B) Same as (A,) except SEP-erbB4-KD was expressed instead of SEP-erbB4.
(C) Images of a CA3 pyramidal cell expressing tDimer DsRed and SEP-NRG1 type III. Scale bar, 10 mm. The boxed axonal region was followed before,
during, and after cLTP induction. Higher magnification pictures of this region, taken at 30 and +40 min relative to cLTP induction, are shown at
below. Quantification of the green (NRG1) over red (tDimer) fluorescence at boutons or axonal regions at each time point during the cLTP experiments
is shown at the right. These values are measurements of relative NRG1 density at each ROI. Each region of interest is normalized to its value at
the 10 min time point. The black bar denotes cLTP induction.
(D) Top: representative traces of AMPARmediated EPSCs from uninfected neurons (left) or neurons expressing erbB4-KD (right). Traces are averaged
for time points before (1) and after (2) LTP induction for the induced pathway (LTP) or control pathway (control). Scale bars, 50 ms and 20 pA. Bottom:
Normalized amplitudes of AMPAR-mediated responses before and after delivery of LTP-induction protocol (arrow).
(E) Same as (D), except that comparison was made between neurons expressing GFP and neurons expressing erbB4-RNAi. *p < 0.05; **p < 0.01
relative to baseline.
Data are reported as mean ± SEM.Neuron 54, 583–597, May 24, 2007 ª2007 Elsevier Inc. 591
Neuron
ErbB4 Controls Synapse Maturation and Plasticityused to monitor SEP-NRG1 type III before, during, and
after cLTP. We quantified the amount of NRG1 on the
boutons or axons as the ratio of the mean green signal
(SEP-NRG1) to the mean red signal (tDimer), which serves
as a relative density of NRG1 on those structures (Kopec
et al., 2006). The cLTP significantly reduced the amount
of NRG1 type III on the surface of axon boutons (bouton
NRG1 at 40 and 70 min were 0.85 ± 0.04 and 0.81 ±
0.03 over base line; n = 32 boutons from four cells, p <
0.05; Figure 7C) and also reduced the amount on other
axonal regions (axonal NRG1 at 40 and 70 min were
0.93 ± 0.05 and 0.87 ± 0.05 over base line; n = 32 regions
from four cells, p < 0.05; Figure 7C). The decrease in NRG1
density is not due to a change in bouton size, since
boutons did not enlarge after cLTP (Figure 7C). The red
signal on the axons was stable during the period of exper-
iments, suggesting the cell condition was good and photo
bleachingwasminimal. The reduction in the surfaceNRG1
type III may result from the processing and subsequent
endocytosis of the surface NRG1, suggesting that the EGF
domain on a subpopulation of NRG1 type III was briefly
exposed and presented to its receptors during cLTP.
To test further whether NRG1/erbB4 is also required for
the conventional, electrically induced LTP, we compared
LTP in CA1 control pyramidal cells or cells expressing
erbB4-KD. ErbB4-KD significantly reduced LTP (control,
n = 7; erbB4-KD, n = 7; p < 0.05 measured between 35
to 45 min; Figure 7D). Similarly, cells expressing erbB4
RNAi also had reduced LTP compared with cells express-
ing only GFP (GFP, n = 16 reduced to 13; erbB4 RNAi, n =
16; p < 0.05 measured between 35 to 45 min; Figure 7E).
We conclude that the normal NRG1/erbB4 signaling is
necessary for both structural and functional LTP.
NRG1/erbB4 Regulates Synaptic Function
and Structure by Stabilizing AMPA Receptors
A previous study from our laboratory showed that the syn-
aptic depression and spine loss resulting from increased
levels of b amyloid can be blocked by stabilizing AMPA re-
ceptors in the synapse (Hsieh et al., 2006). To test whether
stabilizing AMPA receptors could prevent the defect in
synaptic transmission and spine morphology caused by
NRG1/erbB4 loss of function, we examined the effects of
a peptide derived from the AMPA receptor gluR2 C termi-
nus. This peptide, gluR2-3Y, has been shown to stabilize
AMPA receptors in the synapse (Ahmadian et al., 2004).
Strikingly, incubation of slices with gluR2-3Y abolished
the effects of erbB4 RNAi on both synaptic transmission
(AMPA control, 1 ± 0.1; AMPA erbB4 RNAi, 1 ± 0.1, n =
16 pairs, p > 0.05; NMDA control, 1 ± 0.2; NMDA erbB4
RNAi, 0.97±0.2, n=14pairs, p>0.05; Figure 8A) andspine
morphology (spine size, control 1 ± 0.05, n = 302 spines
from four cells; erbB4RNAi, 0.9 ± 0.05, n = 317 spines from
four cells, p > 0.05; spine density, control 0.54 ± 0.04, n =
12 dendritic sections from four cells; erbB4 RNAi 0.52 ±
0.04, n = 13dendritic sections from four cells; p > 0.05; Fig-
ures 8C–8E). Incubation of slices with a mutant version of
the peptide, gluR2-3A, which has no effects on AMPA re-592 Neuron 54, 583–597, May 24, 2007 ª2007 Elsevier Inc.ceptor synaptic stabilization (Ahmadian et al., 2004), had
no effects on erbB4 RNAi-induced synaptic depression
(AMPA control, 1 ± 0.1; AMPA erbB4 RNAi, 0.68 ± 0.1,
n = 16 pairs, p < 0.01; NMDA control, 1 ± 0.2; NMDA
erbB4 RNAi, 0.7 ± 0.1, n = 14 pairs, p < 0.05; Figure 8B).
These results indicate that NRG1/erbB4 signaling controls
synaptic function and structure by regulatingAMPA recep-
tor stabilization in the synapse.
DISCUSSION
A prominent hypothesis regarding the underlying patho-
physiology of schizophrenia has proposed that hypofunc-
tion of the glutamatergic system plays a causal role (Coyle
and Tsai, 2004; Harrison, 2004; Harrison et al., 2003; Har-
rison and Weinberger, 2005). In humans, reducing gluta-
matergic transmission can mimic (Pietraszek, 2003), while
enhancing gluamatergic transmission can alleviate (Javitt,
2004), schizophrenic symptoms. Patients with the disease
show decreased excitatory synaptic function in hippo-
campal and cortical regions (Abbott and Bustillo, 2006;
Bressan and Pilowsky, 2000; Pilowsky et al., 2006).
Another feature thought to be important in the disease is
its neurodevelopmental nature. For example, animals with
lesions that disrupt the excitatory connections between
hippocampus and the frontal cortex early in development
show schizophrenic-like symptoms later in life (Bertolino
et al., 1997; Daenen et al., 2003; Lipska, 2004; Van den
Buuse et al., 2003). Human studies also suggest that
pre- or perinatal brain lesions may lead to schizophrenia
by disrupting early brain maturation processes including
those in the hippocampus (Pantelis et al., 2005; Rehn
et al., 2005). It is thus believed that perturbation of circuitry
formation early in life can predispose to the disease.
Schizophrenia is also a genetic disease.With the advent
of molecular genetics, a number of genes have been
linked to schizophrenia (Harrison and Weinberger, 2005).
The gene with most supportive evidence is nrg1 (Harrison
and Weinberger, 2005; Norton et al., 2006b).
Despite these advances in the field, there has not been
a mechanism that can link genetic perturbation of NRG1
signaling to glutamatergic hypofunction or developmental
abnormalities.
In this study, we examined the function of NRG1/erbB4
signaling in the excitatory CA3-CA1 synapse in the hippo-
campus. Our data support a model in which synaptic ac-
tivity leads to the activation of NRG1/erbB4 signaling
pathway, which recruits or stabilizes erbB4 in the synapse
in amanner that depends on erbB4 PDZ interaction. Activ-
ity-dependent NRG1/erbB4 activation stabilizes synaptic
AMPA receptors and thus permits synaptic plasticity and
synaptic maturation (Figure 8F). Interruption of NRG1/
erbB4 signaling causes destabilization of synaptic
AMPARs and spine structure, leading to impairment in
plasticity and eventually loss of spines and NMDARs.
These results therefore provide a direct link between
NRG1 and glutamatergic function. Decreased NRG1/
erbB4 signaling (which could be longer term but more
Neuron
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Function and Structure by Stabilizing
AMPARs
(A) Neurons were treated with the gluR2-3Y
peptide. Upper: representative traces of
EPSCs recorded simultaneously from a pair of
neurons (black, control neuron; green, neuron
expressing erbB4 RNAi). Scale bars, 50 ms
and 20 pA. Lower: quantification of the EPSCs
mediated by both AMPAR and NMDAR from
pairs of neurons.
(B) Same as (A), except that the neurons were
treated with the gluR2-3A peptide.
(C) Representative images of apical dendrites
from CA1 pyramidal neurons treated with the
gluR2-3Y peptide. Neurons express either
GFP only (control) or erbB4 RNAi.
(D and E) Quantification of the spine size (D)
or density (E) for control neurons and neurons
expressing erbB4 RNAi. Scale bar, 5 mm.
(F) A schematic model for NRG1/erbB4 func-
tion in the synapse. Synaptic activity, including
NMDAR function, leads to activation of post-
synaptic erbB4, which stabilizes synaptic
AMPARs, permitting structural and functional
maturation.
Data are reported as mean ± SEM.modest than the knockdown or dominant-negative pertur-
bations in this study) would likely have manifestations on
excitatory circuit development by inhibiting normal func-
tional and structural synaptic maturation. Thus, our study
provides a link between nrg1 and the ‘‘glutamatergic hy-
pofunction’’ hypothesis as well as with the view that devel-
opment of early circuitry is an important underlying factor
in schizophrenia.
We found an interesting relationship between NRG1/
erbB4 signaling and synaptic activity. Synaptic activity is
required for NRG1/erbB4 signaling, and NRG1/erbB4 sig-
naling enhances synaptic function. Such positive-feed-
back relationships could lead to a switch-like behavior,
where too little activity would lead to a weakening of the
synapse and achieving a threshold level of activity would
lead to its saturation. Since synapses appear to display in-
termediate strengths, there are likely to be other signaling
systems that strongly modulate this switch-like function.
Aberrations of these other modulatory signaling systems
would likely abrogate NRG1/erbB4 signaling and could
contribute to schizophrenia. Our finding that NRG1/erbB4signaling depends on synaptic activity indicates that the
well-known impact of experience on synaptic structure
and function is likely to act, at least in part, through this
signaling pathway.
Several recent studies have examined the acute effects
of NRG1 on synaptic function in the CNS. NRG1 applica-
tion has been shown to inhibit synaptic plasticity (Huang
et al., 2000; Kwon et al., 2005; Ma et al., 2003) and to re-
duce NMDA receptor activity (Gu et al., 2005) or synaptic
transmission (Roysommuti et al., 2003). However, the
interpretation of these data is complicated since these
studies employed tonic application of a functional domain
(such as the EGF domain) of certain isoforms of recombi-
nant NRG1 (Gu et al., 2005; Huang et al., 2000; Kwon
et al., 2005; Ma et al., 2003; Roysommuti et al., 2003),
and little is known about the physiological concentration,
activity duration, location of activity (Wooet al., 2007), spe-
cific NRG1 isoforms involved, as well as different erbB
receptors being activated by such application. The func-
tion of endogenous NRG1 in the synapse may thus be dif-
ferent. Indeed, NRG1-deficient mice have reduced NMDANeuron 54, 583–597, May 24, 2007 ª2007 Elsevier Inc. 593
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et al., 2002), rather than increased NMDA receptor activity
as would be predicted from the acute application studies.
In conclusion, our study indicates a mechanism by
which core features of schizophrenia, including genetic
deficits, developmental abnormalities, and glutamatergic
hypofunction can be linked together. The direct and
chronic perturbation of NRG1/erbB4 signaling, such as
mutations in NRG1 or erbB4 genes that occur in some
schizophrenia patients (Walss-Bass et al., 2006), would
lead to the abnormal development and hypofunction of
glutamatergic synapse and circuitry. Supporting this
view, a decrease in spine density and other markers for
excitatory synapses has been reported in the brain of
schizophrenia patients (Eastwood, 2004; Harrison et al.,
2003; Kristiansen et al., 2006; Lewis et al., 2003). Muta-
tions in nrg1 or erbB4 genes likely account for only a frac-
tion of schizophrenia cases (Harrison and Weinberger,
2005). For other patients, there may be defects in other
signaling or structural components producing hypofunc-
tion in the glutamatergic pathway, and a compensatory in-
crease in NRG1/erbB4 activity or expression level might
be expected. Indeed, an increase in the expression level
of NRG1 isoforms (Hashimoto et al., 2004; Law et al.,
2006; Petryshen et al., 2005) or erbB4 (Silberberg et al.,
2006), as well as an increase in the activity of the NRG1/
erbB4 signaling pathway (Hahn et al., 2006), have been
found in some schizophrenia patients.
EXPERIMENTAL PROCEDURES
Biochemistry on PSD Fraction, Immunoprecipitation
and Western Blotting
These procedures were conducted using standard protocols, for
details, see Supplemental Data.
Plasmid Construction
The superecliptic pHluorin (SEP) coding sequence (Ng et al., 2002) was
inserted after the predicted signal peptide cleavage site of human
erbB4 CYT-2 isoform. The resultant product was inserted into the
mammalian expression vector pCDNA3 (Invitrogen). The kinase-inac-
tive mutant erbB4-KD contains a point mutation (K751M) in the kinase
domain. The red fluorescent proteins (tDimer or tomato DsRed), fast-
maturing obligate dimer versions of DsRed (provided by R. Tsien, Uni-
versity of California San Diego, La Jolla, CA), were inserted into either
pCI (Promega) or pCDNA3. To generate SEP-NRG1, SEP was inserted
into an extracellular region of either NRG1 type I or type III. This region
has been previously used to insert a HA or GFP tag (Ozaki et al., 2004;
Wang et al., 2001). To facilitate imaging of SEP-NRG1, the SEP-NRG1
type III was cloned into a double-promoter Sindbis viral vector that
express both SEP-NRG1 and tDimer. The double-promoter Sindbis
vector was a gift from Dr. H. Nawa.
Short Hairpin RNA-Based RNA Interference for ErbB4 and NRG1
To suppress the expression of endogenous erbB4 or NRG1, short hair-
pin RNAs specifically against rat erbB4 or NRG1 were stably ex-
pressed using a strategy developed in the Hannon lab (Paddison
et al., 2002). To suppress erbB4 or NRG1 expression in neurons, Lenti
virus was used to express both short hairpin RNAs, which is driven by
the U6 promoter (Paddison et al., 2002), and GFP or tDimer, which is594 Neuron 54, 583–597, May 24, 2007 ª2007 Elsevier Inc.driven by the Ubiquitin or Synapsin promoter, to visualize the infected
neurons. The Lenti viral construct, which is similar to what has been
described previously (Dittgen et al., 2004), was a gift from Dr. G. Han-
non. The target sequences of three short hairpin RNAs for erbB4 are
as follows: 50-GCCGTTTATGTCAGAAGGAAG30, 50-CCAGACTACCT
GCAGGAATAC-30, 50-GCCCGCAATGTGTTGGTGAAA-30. The target
sequences of three short hairpin RNAs for NRG1 are as follows: 50-ACT
CAGAAAGTGAGACAGAAG-30, 50-GGCCAGGCTGTCTAGTGTAAT-30,
50-ACGGAGAGCGTCATTTCAGAA-30. These sequences are present
in all three major isoforms of NRG1: NRG1 type I, type II, and type III.
Slice Culture, Transfection, and Other Treatments
Organotypic hippocampal slices were prepared from postnatal day 6
or 7 rats (Stoppini et al., 1991), transfected after 4–6 days in culture,
and used for electrophysiology or imaging experiments 2–3 days after
transfection. Coexpression of two constructs was achieved using biol-
istics transfection (Arnold et al., 1994). For experiments using Lenti
virus infection, slices were infected after 1 day in culture and used
4–7 days after infection for electrophysiology or 7 days after infection
for imaging experiments.
For treatment with gluR2-3Y or -3A peptides, slices were first in-
fected with Lenti virus at day 0. At day 4, the peptides were added
to the medium at a concentration of 5 mm. The peptides were replen-
ished every 24 hr. Recordings were made on day 7. The sequences of
gluR2-3Y and 3A are the same as previously reported (Ahmadian et al.,
2004). A TAT sequence was fused to peptides to aid delivery into the
cell. A dansyl group was also included for visualization of the peptides.
Accumulation of the peptides in neurons was readily detectable by
two-photon laser scanning microscope at a wavelength of 720 nm
(data not shown).
Electrophysiology
Whole-cell recordings were obtained with Axopatch-1D amplifiers
(Axon Instruments). To monitor the effects of different constructs on
synaptic transmission, slices were either transfected biolisticly or in-
fected with Sindbis or Lenti viruses expressing different constructs.
Two days (biolistic), 16–24 hr (Sindbis virus), or 4–7 days (Lenti virus)
later, whole-cell recordingswere obtained simultaneously froma trans-
fected and an adjacent nontransfected neuron in the CA1 region under
visual guidance using epifluorescence and transmitted light illumina-
tion. The recording chamber was perfused with artificial cerebrospinal
fluid (ACSF) containing 119 mM NaCl, 2.5 mM KCl, 4 mMCaCl2, 4 mM
MgCl2, 26 mM NaHCO3, 1 mM NaH2PO4, 11 mM glucose, 0.1 mM
picrotoxin, and 1 mM 2-chloroadenosine (pH 7.4), and gassed with
5% CO2/95% O2. Recordings were made at 27
C. Patch recording
pipettes (3–5 MU) were filled with intracellular solution containing
115 mM cesium methanesulfonate, 20 mM CsCl, 10 mM HEPES,
2.5 mMMgCl2, 4 mM Na2ATP, 0.4 mM Na3GTP, 10 mM sodium phos-
phocreatine, and 0.6 mM EGTA (pH 7.25). Evoked responses were in-
duced using bipolar electrodes placed on Schaffer collateral pathway
or CA3 cell body regions. Responses were recorded at both 60 (for
AMPA receptor-mediated responses) and +40 (for NMDA receptor-
mediated responses) mV. NMDA receptor-mediated responses were
quantified as the mean between 110 and 160 ms after stimulation.
Conventional LTP was induced by pairing postsynaptic depolarization
at 0 mVwith presynaptic stimulation at 3 Hz for 1.5 min. Approximately
one-half of experiments were done and analyzed blind with respect to
construct expressed. Results were similar and thus pooled with non-
blind results. Statistical significance was determined by Student’s
t test or Kolmogorov-Smirnov test. Spontaneous responses (mEPSCs)
were recorded at 27C in the presence of 1 mM TTX and 0.1 mM picro-
toxin and analyzed using Mini Analysis Program (Synaptosoft).
Two-Photon Laser-Scanning Microscopy and cLTP Induction,
Image Display, and Quantitative Image Analysis
Same as that in Kopec et al. (2006), or see Supplemental Data for
details.
Neuron
ErbB4 Controls Synapse Maturation and PlasticitySupplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/54/4/583/DC1/.
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